Slide the table for earlier years · "·" marks a figure not available in our data for that year.
In brief
What this company does
The Parent Company and its subsidiaries provide financial protection to millions of policyholders and customers in Japan and the United States. The Company's principal business is supplemental health and life insurance products. The Company's insurance business consists of two reporting segments: Aflac Japan and Aflac U.S. Aflac Japan is the principal contributor to the Parent Company's consolidated earnings. Aflac Japan pioneered the cancer insurance market in Japan in 1974. Aflac Japan was represented by approximately 6,300 sales agencies at the end of 2025, with approximately 112,000 licensed sales associates employed by those agencies, including individual agencies. The Company designs its U.S. insurance products to provide supplemental coverage for people who already have major medical or primary insurance coverage, and Aflac U.S. insurance policies pay benefits regardless of other insurance. Aflac Incorporated was incorporated in 1973 under the laws of the state of Georgia.
Written from the business description in AFLAC INC's annual report to the U.S. Securities and Exchange Commission, filed 25 February 2026. Every sentence was checked against that document before publication.
Revenue compounded at −5.0% a year over the five years to FY2025.
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Every figure from documents filed with the SEC · USD
EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.
row low → row highnegative—not applicable◌not available in our data